Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romosozumab in Metastatic Breast Cancer with Osteoporosis
NCT07776613Phase 2Recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Aug 2026
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
A Phase 2 trial of romosozumab in osteoporosis, sponsored by Memorial Sloan Kettering Cancer Center. Started Aug 2026; status: recruiting.
02
Drugs
romosozumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT07776613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07776613.